[vc_row][vc_column width=”1/1″][pt_heading h=”H1″ heading=”Non-Dilutive Funding Summit” text_align=”align-left”][pt_marginblock measure=”px”]50[/pt_marginblock][pt_leadtext text_align=”align-left”]

Join over 400 life science industry leaders in a full day of non-dilutive funding activities at the 10th Annual Non-dilutive Funding Summit, taking place on Wednesday January 14th, 2015 at the Nikko Hotel San Francisco.

The summit is proud to host Dr. Rajesh Ranganathan, the Director of the Office of Translational Research at the National Institute of Neurological Disorders and Stroke (NINDS; NIH) who will describe the NINDS and NIH funding opportunities and other resources available to the community that facilitate and enhance biomedical technology development towards commercialization.

[/pt_leadtext][pt_marginblock measure=”px”]50[/pt_marginblock][vc_button title=”Event Website” target=”_blank” color=”wpb_button” icon=”none” size=”btn-large” href=”http://www.freemindconsultants.com/10th-annual-non-dilutive-funding-summit-2/”][vc_button title=”Register Now!” target=”_blank” color=”btn-primary” icon=”none” size=”btn-large” href=”https://www.eventbrite.com/e/10th-annual-non-dilutive-funding-summit-tickets-10802674089″][/vc_column][/vc_row]

Weekly Online Educational Webinars – July 2nd – August 27th, 2014

FreeMind’s knowledgeable team of expert grant writers share their wisdom on how to maximize chances for award.

Participation is FREE of Charge, Registration is Required

Date Title
July 16th Biodefense and Infectious Diseases Non-dilutive Funding
July 23rd RO1 and R21s for Companies
July 30th Non-Dilutive funding for Non-US applicants
August 6th Cancer Non-dilutive Funding
August 13th CNS/PNS Related Non-Dilutive Funding Opportunities
August 20th Details of a Detailed Budget; Accurately Constructed and well Justified
August 27th Medical Device Non-Dilutive Funding: Trends & Opportunities
September 3rd SBIR/STTR
September 10th Registration ins and outs; smooth sailing to an error free submission

 

Register

The FreeMind Group and CONNECT are pleased to invite you to a full day of non-dilutive funding activities on June 23rd at the Procopio Law offices
 – 525 B Street, Suite 2200 –

 

Participation is FREE of charge

 

Seating is limited, so please register in advance to reserve
AGENDA
Non-dilutive Funding During the BIO International Convention
08:00 Pre-Conference Workshop – RO1 for CompaniesAyal RonenVice President, FreeMind Group
SBIR/STTR awards account for roughly $750M directed at small businesses. An additional $600M are awarded through other mechanisms. Learn from the experts how to maximize your funding potential
08:30 Breakfast and Networking
09:00 Welcome Remarks
CONNECTGreg MckeeCEO, CONNECT
CONNECT is a regional program  that catalyzes the creation of innovative technology and life sciences products in San Diego County by linking inventors and entrepreneurs with the resources they need for success
09:15 Presentation: Non-Dilutive Funding Driving Innovation in the Private SectorRam May-Ron
Managing Partner, FreeMind Group
For profit entities are eligible for the majority of the $50B allocated annually via non-dilutive sources of funding which are considered a powerful force driving innovation in the private sector. Learn more during the presentation by Ram May-Ron from the FreeMind Group
10:15 Break
10:30 Presentation: IP Protection in an “Open Science” Environment
Michael Kinkelaar
Partner at Procopio, Cory, Hargreaves & Savitch
The Bayh-Dole Act which has protected and encouraged transformative, breakthrough research. However, it was not originally designed with “Open Science” in mind.  When should institutions seek outside IP counsel?  Share your experiences and join this discussion
11:00 Meet a non-dilutive funding expert To schedule a 1×1 meeting with a funding expert click here
12:00 Break
1:00 Presentation: Non-Dilutive Sources of Funding for Non-US ApplicantsAyal Ronen
Vice President, FreeMind Group
Every year NIH alone awards over $1,3B to non-US organizations. Learn how to target such sources as well as maximize your chances for award
2:00 Meet a non-dilutive funding expert To schedule a 1×1 meeting with a funding expert click here

!NIH/DOD Non-dilutive Funding Opportunities; Non-US Applicants are Welcome

Presenter:  Ayal Ronen, Vice President, FreeMind Group

Agenda:

9:00-09:30 Registration and networking breakfast
09:30-10:30 Presentation
10:30-10:45 Q&A
11:00-12:00 Meet the expert – 1X1 meetings with the FreeMind team

REGISTRATION

Presentation Outline

Currently, the National Institutes of Health (NIH) are actively funding 1,124 projects amounting to $1.3B, taking place outside the US and awarded to non-US applicant organizations. And, when taking into account collaborations and partnerships between domestic and foreign entities, the funded R&D dollars outside the US even exceed the above.

In this presentation Ayal Ronen, FreeMind’s Vice President will provide insight into the non-dilutive funding landscape with an emphasis on the NIH, Department of Defense and other government agencies. Mr. Ronen will describe the various pockets of money available for non-US applicants, potential for funding, and means to maximize chances for award.

To schedule a 1X1 meeting with Ayal Ronen, please contact:

Carla Hamoy at:  [email protected], 617-6480340 ext 249

The FreeMind Group and the 9th Annual Non-Dilutive Funding Summit is proud to host Dr. Anthony Boccanfuso, Executive Director, The National Academies’ University-Industry Demonstration Partnership (UIDP) who will discuss in his presentation industry-academic collaborations and how the life science industry can leverage such ties to secure non-diltuive capital to fund their R&D activities.

Following the presentation, Dr. Boccanfuso will lead a panel discussion featuring top industry executives who will detail how non-dilutive funding substantially assisted in maintaining a sustainable business while promoting their R&D efforts.

Panelists:
Dr. Eric Patzer
Founder and President, Aridis Pharmceuticals

Dr. Scott Thatcher
CEO & Founder, Orphagen

Dr. Timothy A Antaya
CEO, Antaya Science and Technology

James Knighton
CEO, AvidBiotics

FreeMind Group and the 9th  Annual Non-Dilutive Funding Summit are proud to host Dr. Larry Mahan of the National Heart, Lung, and Blood Institute (NHLBI; NIH) who will share her insight into the NHLBI’s interests and funding agenda, as well as the NIH funding opportunities and other resources available to the community that facilitate and enhance biomedical technology development towards commercialization.

The 9th Annual Non-dilutive Funding Summit is proud to host Ram May-Ron, Managing Partner,  FreeMind Group who will give a presentation on a “2014 Non-Dilutive Funding Forecast”. In his presentation Mr May-Ron will share his insight into Life Science funding trends and specifically non-dilutive funding as the driving force in this sector.

[vc_row][vc_column width=”1/1″][pt_heading h=”h3″ heading=” Join over 250 life science industry leaders in a full day of non-dilutive funding activities at the 9th Annual Non-dilutive Funding Summit, taking place on Wednesday January 15th, 2014 at the Nikko Hotel San Francisco. ” text_align=”align-left”][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][vc_separator][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][pt_text text_align=”align-left”]

The summit is proud to host Dr Jodi Black of the National Heart Lung and Blood Institute (NHLBI; NIH) who will describe the NHLBI and NIH funding opportunities and other resources available to the community that facilitate and enhance biomedical technology development towards commercialization.
Anthony Buccanfuso of The University Industry Demonstration Partnerships (UIDP) will present and host a panel on Industry-Academia partnerships and the makings of a successful collaboration.
Throughout the day workshops and focused discussions on specific areas of interest will be lead by Guy Har-Chen, Chief Analyst, FreeMind Group. The summit will begin with a “non-dilutive funding forecast” to be presented by Ram May-Ron, Managing Partner, FreeMind Group.

[/pt_text][/vc_column][/vc_row][vc_row][vc_column width=”1/3″][/vc_column][vc_column width=”1/3″][vc_button title=”Register Now!” target=”_blank” color=”btn-danger” icon=”none” size=”btn-large” href=”https://events.r20.constantcontact.com/register/eventReg?oeidk=a07e8bm1j5f69330bd6&oseq=&c=&ch=”][/vc_column][vc_column width=”1/3″][/vc_column][/vc_row]

Presentation at the Harvard Innovation Lab by Ram May-Ron, Managing Partner FreeMind.

Synopsis:

Explore ways to maximize funding for science companies from non-dilutive funding sources such as NIH, DOD SBIRs (Small Business Innovation Research) and other federal and private sources. Learn about successful strategies for building a multi-submission strategy and academia-industry collaborations in the pursuit of non-dilutive grants and contracts from SBIR $100K awards to large-scale collaborative funding $10M and more to support biomedical research development. Ram May-Ron, Managing Partner of FreeMind Group (www.freemindconsultants.com), examines the challenges and offers insightful tips to facilitate effective collaborations that lead to funding success.

The discussion includes consortia, center, and/or program mechanisms from major biomedical sponsors such as the National Institutes of Health (NIH) and the Department of Defense (DoD) and academic-industry partnerships that seek sponsored research funding via Small Business (SBIR and STTR) and other programs.

Currently, the National Institutes of Health (NIH) are actively funding 1,124 projects amounting to $1.3B, taking place outside the US and awarded to non-US applicant organizations. And, when taking into account collaborations and partnerships between domestic and foreign entities, the funded R&D dollars outside the US even exceed the above.

In this presentation Ayal Ronen, FreeMind’s Vice President will provide insight into the non-dilutive funding landscape with an emphasis on the NIH, Department of Defense and other government agencies. Mr. Ronen will describe the various pockets of money available for non-US applicants, potential for funding, and means to maximize chances for award.

Agenda:

9:30-10:00 Registration and networking breakfast

10:00-11:00 Presentation

NIH/DOD Non-dilutive Funding Opportunities; non-US applicants  are  welcome!

Presenter:  Ayal Ronen, Vice President, FreeMind Group

11:00-11:15 Q&A

11:15-12:00 Meet the expert – 1X1 meetings with the FreeMind team

Dr Sigal Katz – Senior Analyst, FreeMind Group

Ayal Ronen, Vice President, FreeMind Group